EMA News
🇪🇺 EMA Page 6EMA news and analysis for pharmaceutical BD, investment, and market access · 9 articles on this page
Get critical EMA regulatory updates for drug approvals, clinical trials, and market access in Europe & UK. Stay ahead of pharma compliance.
Showing 61–69 of 69 articles
Real-World Evidence in EU: Leveraging EHRs for Regulatory Decisions
EMA Conditional Approval CAR-T Therapy for Relapsed B-Cell Lymphoma
EMA Issues Positive Opinion for Zepzelca (Lurbinectedin) in Cancer Treatment
EMA Backs Amgen's Tarlatamab as First-in-Class BiTE Therapy for Advanced Small Cell Lung Cancer
EMA Issues Positive Opinion for Adstiladrin Gene Therapy in Bladder Cancer Treatment
EMA Recommends First Bispecific T-Cell Engager for Relapsed Small Cell Lung Cancer
EMA Advances Virtual Control Groups to Reduce Animal Testing in Drug Development
EMA Accelerated Assessment of Novel mRNA Vaccine Platforms for Pandemic Preparedness
Orphan Drug Pricing EU: Market Analysis and Reimbursement Trends